Providing the infrastructure for research

research1


The Woodruff Health Sciences Center invested a total of $112.8 million in research costs unrecovered from sponsors last year.


Investigators in medicine, nursing, public health, and Yerkes National Primate Research Center garnered more than $540 million in research awards in fiscal year 2015-2016, many of these with international, national, and local partners, such as Georgia Tech and University of Georgia.

This research total included a $35.6 million grant to lead a multidisciplinary consortium focused on HIV vaccine and cure research; $9.7 million to develop drugs to treat emerging and man-made viral threats; $8.9 million to explore strategies to prevent atherosclerosis and aortic aneurysms; $8.3 million to establish a laboratory in a national network of laboratories to measure the impact of environmental chemicals on children’s health; $6.4 million to develop better treatments for malaria; $5.2 million to study links between blood pressure regulation and Alzheimer’s; $5 million to study interactions between toxicant exposures and the microbiome and their impact on preterm birth, infant health, and neurodevelopment among African American mothers and babies; $2.8 million to develop nanoparticles to treat pancreatic cancer; $2.4 million to develop a breast cancer vaccine; and $2.2 million to prevent the spread of infectious disease in health care facilities, among others.

These grants and contracts move research forward to benefit society and create thousands of jobs. This research would not be possible, however, without facilties and other infrastructure support provided by the Woodruff Health Sciences Center. In fiscal year 2016, for example, the WHSC invested $112.8 million in research-support costs unrecovered from sponsors.


research2


     
 

Some Emory research highlights from the past year

■ Launched an antibiotic resistance center to identify and consolidate expertise on this increasingly urgent issue

■ Assembled teams to study Zika and develop a vaccine and drugs against it

■ Launched largest-ever clinical research study in Atlanta, on brain health

■ Partnered with Georgia Tech and others to create a new Regional Big Data Hub to address regional challenges in health care and other areas

■ Offered patients access to more than 900 clinical research studies of new drugs and devices